Picture of Antengene logo

6996 Antengene Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Annual income statement for Antengene, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue28.816067.392105
Cost of Revenue
Gross Profit24.21325575.388
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses684761648411342
Operating Profit-655-601-580-319-237
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-656-601-581-319-239
Provision for Income Taxes
Net Income After Taxes-656-601-581-319-239
Net Income Before Extraordinary Items
Net Income-656-601-581-319-239
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-656-601-581-319-239
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1.05-0.974-0.94-0.515-0.381